(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Disruption of the Fgfr2 alleles in prostate epithelium.
(A) Schematic of the floxed Fgfr2 alleles for conditional
disruption. The genomic DNA containing exons 6-10 and the adjacent introns is
shown. The primers for PCR genotyping and FGFR2 expression analyses are
indicated. (B) The Fgfr2cn alleles only encode a
truncated ectodomain. (C) PCR genotyping. Genomic DNAs extracted from
different lobes of Fgfr2cn and control prostates of
3-week-old mice were PCR analyzed with the indicated primers. Primers f1 and
f2 amplify a fragment of 207 bp from floxed Fgfr2 alleles. Primers f1
and f3 amplify a fragment of 471 bp from Fgfr2-null alleles, and give
no amplification for wild-type Fgfr2 or Fgfr2flox
alleles. (D,E) Diminished FGFR2 expression in the epithelium of
Fgfr2cn prostates. The expression of FGFR2 was assessed
with RT-PCR (D) and in situ hybridization (E). Primers R2f and R2r amplify
both FGFR2IIIb (IIIb) and FGFR2IIIc (IIIc) isoforms; primers b and t only
amplify FGFR2IIIb isoform, primers c and t only amplify FGFR2IIIc isoform. -,
negative control without cDNA templates. Panel E shows strong expression of
FGFR2 in the epithelial compartment of control prostates, which was diminished
in Fgfr2cn prostates. ap, anterior prostate; dlp,
dorsolateral prostate; vp, ventral prostate; S, signal peptide; I/II/III,
immunoglobulin loop I, II and III, respectively; TM, transmembrane domain;
F/F, homozygous Fgfr2flox mice; CN,
Fgfr2cn mice.